Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome.

David SchibilskyChristoph HallerBruno LangeBarbara SchibilskyHelene HaeberlePeter SeizerMeinrad GawazPeter RosenbergerTobias WalkerChristian Schlensak

Published in: PloS one (2017)

LVAD implantation in ECLS patients leads to improvement of INTERMACS level to INTERMACS III TCS status. Excellent mid-term survival comparable to true INTERMACS III-IV patients could be shown. ECLS prior to LVAD as a bridge-to-bridge therapy may help to lower mortality in primarily unstable patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
stem cells
cardiovascular disease
risk factors
patient reported